| KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
0.56 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
SNF1LK2 |
SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 |
0.56 |
Evidence |
|
| AP1G2 |
AP1G2: AP-1 complex subunit gamma-2 |
AP1G1 |
AP1G1, ADTG, CLAPG1: AP-1 complex subunit gamma-1 |
0.56 |
Evidence |
|
| CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
TSHR |
IPI00386365 |
0.557 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.557 |
Evidence |
|
| TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
EHD2 |
EHD2, PAST2: EH domain-containing protein 2 |
0.557 |
Evidence |
|
| CXCL12 |
Stromal cell-derived factor 1 delta |
TSHR |
IPI00386365 |
0.557 |
Evidence |
|
| IL2 |
IL2: Interleukin 2 |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.557 |
Evidence |
|
| CCR5 |
CCR5: CCR5 receptor (Fragment) |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
0.557 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
JAK1 |
|
0.557 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
LYN |
LYN: Tyrosine-protein kinase Lyn |
0.557 |
Evidence |
|
| CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.557 |
Evidence |
|
| SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
0.557 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.557 |
Evidence |
|
| EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.557 |
Evidence |
|
| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.557 |
Evidence |
O
|
| CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.557 |
Evidence |
|
| THOC1 |
THOC1, HPR1: THO complex subunit 1 |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
0.557 |
Evidence |
|
| CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.557 |
Evidence |
|
| GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
GNAI2 |
Galphai2 protein |
0.557 |
Evidence |
|
| LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.557 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.557 |
Evidence |
|
| EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.557 |
Evidence |
|